Elsevier: Goodman & Snyder: Differential Diagnosis for Physical Therapists Screening for Referral, 5th Edition - Chapter 13 Screening for Cancer

Chapter 13 Screening for Cancer

  1. Siegel R, Ward E, Brawley O, et al: Cancer statistics 2011. CA Cancer J Clin 61:212–236, 2011. Medline abstracts
  2. Brem SN, Nabors LB, Raizer JJ: Central nervous system cancers, National Comprehensive Cancer Guidelines (2009). Available at http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed November 01, 2010.
  3. National Cancer Institute (NCI): Annual report: Continued declines in annual cancer rates, 2009. Available at www.nci.nih.gov/. Accessed Oct 29, 2010.
  4. Oeffinger KC, Mertens AC, Hudson MM, et al: Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Fam Med 2:61–70, 2004. Medline abstracts
  5. University of Minnesota Cancer Center: Childhood Cancer Survivor Study (CCSS). Available at http://www.cancer.umn.edu/ltfu. Accessed Oct. 11, 2010.
  6. Hawkins M: Long-term survivors of childhood cancers: what knowledge have we gained? Available at www.medscape.com/viewarticle/492506. Accessed Oct. 11, 2010.
  7. Tsao A, Kim E, Hong W: Chemoprevention of cancer. CA Cancer J Clin 54:150–180, 2004. Medline abstracts
  8. Guide to Physical Therapist Practice, ed 2, Alexandria, VA, 2003, American Physical Therapy Association.
  9. American Cancer Society (ACS): Cancer prediction and early detection (CPED), Atlanta, 2010, ACS. Available at www.cancer.org. Accessed Oct. 11, 2010.
  10. National Cancer Institute: Cancer Statistics. Available at http://www.nci.nih.gov/statistics/. Accessed Oct. 11, 2010.
  11. Pal SK, Katheria V, Hurria A: Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin 60(2):120–132, 2010. Medline abstracts
  12. Ries LAG, Eisner MP, Kosary CL: SEER Cancer Statistics Review, Bethesda, MD, 1973-1999, NCI. Available at http://seer.cancer.gov/csr/1973_1999/. Accessed September 2002.
  13. Bach PB, Schrag D, Brawley OW: Survival of blacks and whites after a cancer diagnosis. JAMA 287:2106–2113, 2002. Medline abstracts
  14. Institute of Medicine (IOM): Unequal treatment, confronting racial and ethnic disparities in health care, Washington DC, 2003, IOM. Available at http://www.iom.edu/ [type in search window: Unequal Treatment]. Accessed Oct. 11, 2010.
  15. O’Brien K: Cancer statistics for Hispanics, 2003. CA Cancer J Clin 53:208–226, 2003. Medline abstracts
  16. Huerta EE: Cancer statistics for Hispanics, 2003: good news, bad news, and the need for a health system paradigm change. CA Cancer J Clin 53:205–207, 2003. Medline abstracts
  17. Ziogas A: Clinically relevant changes in family history of cancer over time. JAMA 306:172–178, 208–210, 2011.
  18. Sifri R, Gangadharappa S, Acheson L: Identifying and testing for hereditary susceptibility to common cancers. CA Cancer J Clin 54:309–326, 2004.
  19. National Society of Genetic Counselors (NSGC): Your family history: your future, Chicago, IL, NSGC. Available at www.nsgc.org. Accessed Oct. 11, 2010.
  20. American Institute for Cancer Research (AICR): Food, nutrition, physical activity and the prevention of cancer: a global perspective, Washington, DC, 2007, AICR.
  21. American Institute for Cancer Research (AICR): Expert Panel Report: Summary—food nutrition and the prevention of cancer: a global perspective, Washington, DC, 2005, AICR. Available at http://www.aicr.org/. Accessed Oct. 10, 2010.
  22. Calle EE, Rodriquez C, Walker-Thurmond K, et al: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638, 2003. Medline abstracts
  23. Patel AV, Rodriquez C, Bernstein L, et al: Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 14:459–466, 2005. Medline abstracts
  24. Key TJ, Schatzkin A, Willett WC, et al: Diet, nutrition, and the prevention of cancer. Public Health Nutr 7:187–200, 2004. Medline abstracts
  25. Roberts DL: Biological mechanisms linking obesity and cancer risk: new perspectives. Ann Rev Med 61:301–316, 2010. Medline abstracts
  26. Harriss DJ: Lifestyle factors and colorectal cancer risk: systematic review and meta-analysis of associations with mass index. Colorectal Dis 11(6):547–563, 2009. Medline abstracts
  27. Mai V, Kant AK, Flood A, et al: Diet quality and subsequent cancer incidence and mortality in a prospective cohort of women. Int J Epidemiol 34:54–60, 2005. Medline abstracts
  28. Kabat GC: Repeated measures of serum glucose and insulin in relationship to postmenopausal breast cancer. Int J Cancer 125(11):2704–2710, 2009. Medline abstracts
  29. Duggan C: Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol 29(1):32–39, 2011. Epub Nov 29, 2010. Medline abstracts
  30. Eyre H, Kahn R, Robertson RM: Preventing cancer, cardiovascular disease and diabetes: a common agenda for the ACS, American Diabetes Association, American Heart Association. CA Cancer J Clin 54:190–207, 2004. Medline abstracts
  31. National Cancer Institute (NCI): Nutrition in cancer care 2010. Available on-line at http://www.cancer.gov/cancertopics/pdq/supportivecare/nutrition/Patient/page1. Accessed March 7, 2011.
  32. American Cancer Society (ACS): Nutrition for people with cancer. Available on-line at www.cancer.org. Accessed March 7, 2011.
  33. American Institute for Cancer Research: Diet and Cancer Materials. Food, Nutrition, Physical Activity and the Prevention of Cancer. Available on-line at www.dietandcancerreport.org. Accessed March 7, 2011.
  34. Renehan AG: Interpreting the epidemiological evidence linking obesity and cancer. Eur J Cancer 46(145):2581–2592, 2010. Medline abstracts
  35. Chen YC, Hunter D: Molecular epidemiology of cancer. CA Cancer J Clin 55:45–54, 2005. Medline abstracts
  36. National Cancer Institute: Fact sheet: human papillomaviruses and cancer: questions and answers. Available on-line at http://www.cancer.gov/cancertopics/factsheet/Risk/HPV. Accessed October 11, 2010.
  37. CDC: Sexually transmitted diseases. Genital HPV infection—CDC fact sheet, 2010. Available online at http://www.cdc.gov/std/hpv/stdfact-hpv.htm. Accessed October 11, 2010.
  38. Fleming DT: Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337:1105–1160, 1997. Medline abstracts
  39. Centers for Disease Control and Prevention, National Center for Health Statistics: National Vital Statistics Report: Sexually transmitted infections, Hyattsville, MD, 2009, CDC.
  40. Centers for Disease Control and Prevention (CDC): Tracking the hidden epidemics 2000: Trends in STDs in the United States, Hyattsville, MD, 2000, CDC. Available at http://www.cdc.gov/. Accessed Oct. 10, 2010.
  41. Armbruster C, Dekan G, Hovorka A: Granulomatous pneumonitis and mediastinal lymphadenopathy due to photocopier toner dust. Lancet 348:1518–1519, 1996.
  42. Gallardo M, Romero P, Sanchez-Quevedo MC, et al: Siderosilicosis due to photocopier toner dust. Lancet 412–413, 1994.
  43. US Justice Department: Radiation Exposure Compensation Program. Available at www.usdoj.gov/civil/torts/const/reca/. Accessed Oct. 10, 2010.
  44. National Cancer Institute (NCI): About radiation fallout. report on exposure to iodine 131 from atomic bombs detonated above ground at the nevada test site: fact sheets, a dose calculator, and state and county exposures. Available at rex.nci.nih.gov/INTRFCE_GIFS/radiation_fallout/radiation_131.html. Accessed Oct. 10, 2010.
  45. Centers for Disease Control and Prevention (CDC): A Feasibility study of the health consequences to the American population from nuclear weapons tests conducted by the United States and other nations. Available at www.cdc.gov/nceh/radiation/fallout/default.htm. Accessed Oct. 11, 2010.
  46. United States Department of Energy: DOE Nevada: Detailed, historical reports on nuclear testing at the Nevada test site. Available at www.nv.doe.gov/news&pubs/publications/historyreports/default.htm. Accessed Oct. 10, 2010.
  47. National Safety Council (NSC): Understanding radiation. Sources of nonionizing radiation, Posted Dec. 2, 2005. Available at http://www.nsc.org/. Accessed Oct 10, 2010.
  48. El Ghissassi F, Baan R, Straif K, et al: A review of human carcinogens. Part D: radiation. Lancet Oncol 10(8):751–752, 2009. Medline abstracts
  49. Lazovich D: Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev 19(6):1557–1568, 2010. Medline abstracts
  50. Woo DK: Tanning beds, skin cancer, and vitamin D: An examination of the scientific evidence and public health implications. Dermatol Ther 23(1):61–71, 2010. Medline abstracts
  51. Frumkin H: Agent orange and cancer: an overview for clinicians. CA Cancer J Clin 53:245–255, 2003. Medline abstracts
  52. Air Force Research Laboratory: Air Force health study. Available at http://www.wpafb.af.mil/AFRL/. Accessed Oct. 10, 2010.
  53. Institute of Medicine (IOM): Reports: veterans and agent orange: update 2008. Available at http://www.iom.edu. Accessed Oct 30, 2010.
  54. Marshall L: Identifying and managing adverse environmental health effects: taking an exposure history. Can Med Assoc J 166:1049–1054, 2002. Available at www.cmaj.ca/cgi/reprint/166/8/1049.pdf. Accessed Oct. 10, 2010.
  55. Omenn GS: Genomics and prevention: a vision for the future. Medscape Public Health & Prevention 3(1). Available at http://www.medscape.com/viewarticle/501299. Accessed Oct. 10, 2010.
  56. Lindsey H: Environmental factors & cancer: research roundup. Oncology Times 27(4):8–10, 2005.
  57. Joerger AC, Fersht AR: The tumor suppressor p53: from structures to drug discovery. Cold Spring Harb Perspect Biol 2(6):a000919, 2010.
  58. Maslon MM, Hupp TR: Drug discovery and mutant p53. Trends Cell Biol 20(9):542–555, 2010. Medline abstracts
  59. Couzin J: Choices—and uncertainties—for women with BRCA mutations. Science 302:592, 2003.
  60. Rose PS, Buchowski JM: Metastatic disease in the thoracic and lumbar spine: evaluation and management. J Am Acad Orthop Surg 19(1):37–48, 2011. Medline abstracts
  61. Kitagawa Y, Fujii H, Mukai M, et al: Intraoperative lymphatic mapping and sentinel lymph node sampling in esophageal and gastric cancer. Surg Oncol Clin N Am 11:293–304, 2002. Medline abstracts
  62. McGarvey CL: Principles of oncology for the physical therapist, Long Island, NY, 2003, Stony Brook University.
  63. Fagan A: Bone metastases in breast cancer. Rehabil Oncol 22:23–26, 2004.
  64. Lipton A: Bone continuum of cancer. Am J Clin Oncol 33(3):Suppl. S1–S7, 2010. Medline abstracts
  65. Eatock AM, Scatzlein A, Kayes L: Tumour vasculature as a target for anticancer therapy. Cancer Treat Rev 26:191–204, 2000. Medline abstracts
  66. Diaz NM, Vrcel V, Centeno BA, et al: Modes of benign mechanical transport of breast epithelial cells to axillary lymph nodes. Adv Anat Pathol 12:7–9, 2005. Medline abstracts
  67. Mankin HJ, Mankin CJ, Simon MA: The hazards of the biopsy revisited. J Bone Joint Surg 78A:656–663, 1996.
  68. Springfield DS, Rosenberg A: Biopsy: complicated, risky (editorial). J Bone Joint Surg 78A:639–643, 1996.
  69. Abdu WA, Provencher M: Primary bone and metastatic tumors of the cervical spine. Spine 23:2767–2777, 1998. Medline abstracts
  70. Austin JP: Probable causes of recurrence in patients with chordoma and chondrosarcoma of the base of skull and cervical spine. Int J Radiat Oncol Biol Phys 25:439–444, 1993. Medline abstracts
  71. Fischbein NJ: Recurrence of clival chordoma along the surgical pathway. Am J Neuroradiol 21:578–583, 2000. Medline abstracts
  72. Bergh P: Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 88:2122–2134, 2000. Medline abstracts
  73. Slipman CW: Epidemiology of spine tumors presenting to musculoskeletal physiatrists. Arch Phys Med Rehab 84:492–495, 2003.
  74. American Academy of Dermatology (ADD): Melanoma fact sheet 2010. Available at www.aad.org. Accessed Oct. 11, 2010.
  75. American Cancer Society: Skin cancer 2010. Available at www.cancer.org. Accessed Oct. 30, 2010.
  76. Chen K, Craig JC, Shumack S: Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. Br J Dermatol 152:518–523, 2005. Medline abstracts
  77. Ross MI: Aid for patients with limb metastases. World Melanoma Update 1:15, 1997.
  78. Rigel DS: The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin 60(5):301–316, 2010. Medline abstracts
  79. Gudas S: The physical therapy challenge in disseminated cancer. Oncol Sect News APTA 5:3, 1987.
  80. Thomas SS, Dunbar EM: Modern multidisciplinary management of brain metastases. Curr Oncol Rep 12(1):34–40, 2010. Medline abstracts
  81. Jaeckle KA: Neurological manifestations of neoplastic and radiation-induced plexopathies. Semin Neurol 24:385–393, 2004. Medline abstracts
  82. Jaeckle KA: Neurologic manifestations of neoplastic and radiation-induced plexopathies. Semin Neurol 30(3):254–262, 2010. Medline abstracts
  83. Prasad D, Schiff D: Malignant spinal cord compression. Lancet Oncol 6:15–25, 2005. Medline abstracts
  84. Pigott KH, Baddeley H, Maher EJ: Pattern of disease in spinal cord compression on MRI scan and implications for treatment. Clin Oncol (R Coll Radiol) 6:7–10, 1994.
  85. Morris GS: Oncologic emergencies. Acute Care Perspectives 16(4):1, 3–7, 2007.
  86. Coleman RE: Management of bone metastases. Oncologist 5:463–470, 2000. Medline abstracts
  87. Schiff D: Peer viewpoint. J Support Oncol 2:398, 401, 2004.
  88. Abrahm JL: Assessment and treatment of patients with malignant spinal cord compression. J Support Oncol 2:377–401, 2004. Medline abstracts
  89. Levack P, Graham J, Collie D, et al: Scottish Cord Compression Study Group. Don’t wait for a sensory level—listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression. Clin Oncol (R Coll Radiol) 14:472–480, 2002.
  90. Schiff D: Spinal cord compression. Neurol Clin 21:67–86, 2003. Medline abstracts
  91. Tatu B: Physical therapy intervention with oncological emergencies. Rehabil Oncol 23:4–6, 2005.
  92. Ampil FL, Mills GM, Burton GV: A retrospective study of metastatic lung cancer compression of the cauda equina. Chest 120:1754–1755, 2001. Medline abstracts
  93. Orendacova J, Cizkova D, Kafka J, et al: Cauda equina syndrome. Prog Neurobiol 64:613–637, 2001. Medline abstracts
  94. Bagley CA, Gokaslan ZL: Cauda equina syndrome caused by primary and metastatic neoplasms. Neurosurg Focus 16(6), 2004. Available online at http://www.medscape.com/viewarticle/482042_print. Accessed Oct. 11, 2010.
  95. Small SA, Perron AD, Brady WJ: Orthopedic pitfalls: cauda equina syndrome. Am J Emerg Med 23:159–163, 2005. Medline abstracts
  96. Uchiyama T, Sakakibara R, Hattori T, et al: Lower urinary tract dysfunctions in patients with spinal cord tumors. Neurourol Urodyn 23:68–75, 2002.
  97. McCarthy MJH: Cauda equina syndrome. Factors affecting long-term functional and sphincteric outcome. Spine 32(2): 207–216, 2007. Medline abstracts
  98. Hile ES: Persistent mobility disability after neurotoxic chemotherapy. Phys Ther 90(11):1649–1657, 2010. Medline abstracts
  99. Bataller A, Dalman J: Paraneoplastic disorders of the central nervous system: update on diagnosis and treatment. Semin Neurol 24:461–471, 2004. Medline abstracts
  100. Santacroce L: Paraneoplastic syndromes. eMedicine Specialties, 2010. Available online at www.emedicine.com/med/TOPIC1747.HTM. Accessed March 7, 2011.
  101. Velez A, Howard MS: Diagnosis and treatment of cutaneous paraneoplastic disorders. Dermatol Ther 23(6):662–675, 2010. Medline abstracts
  102. Briani C: Spectrum of paraneoplastic disease associated with lymphoma. Neurology 76(8):705–710, 2011. Medline abstracts
  103. Maverakis E: The etiology of paraneoplastic autoimmunity. Clin Rev Allergy Immunol Jan 19, 2011. Epub ahead of print.
  104. Farrugia ME: Myasthenic syndromes. J R Coll Physicians Edinb 41(1):43–48, 2011. Medline abstracts
  105. Naschitz JE: Musculoskeletal syndromes associated with malignancy. Curr Opin Rheumatol 20(1):100–105, 2008. Medline abstracts
  106. Stummvoll GH, Aringer M, Machold KP, et al: Cancer polyarthritis resembling rheumatoid arthritis as a first sign of hidden neoplasms. Scand J Rheumatol 30:40–44, 2001. Medline abstracts
  107. Martorell EA, Murray PM, Peterson JJ, et al: Palmar fasciitis and arthritis syndrome associated with metastatic ovarian carcinoma: a report of four cases. J Hand Surg 29A:654–660, 2004.
  108. Stummvoll GH, Graninger WB: Paraneoplastic rheumatism—musculoskeletal diseases as a first sign of hidden neoplasms. Acta Med Austriaca 29:36–40, 2002. Medline abstracts
  109. Klippel JH: Primer on the rheumatic diseases, ed 13, Arthritis Foundation, New York, 2008, Springer Science Media.
  110. Joines JD, McNutt RA, Carey TS, et al: Finding cancer in primary care outpatients with low back pain: a comparison of diagnostic strategies. J Gen Intern Med 16:14–29, 2001. Medline abstracts
  111. Deyo RA, Diehl AK: Cancer as a cause of back pain: frequency, clinical presentation, and diagnostic strategies. J Gen Intern Med 3:230–238, 1988. Medline abstracts
  112. Jarvik J, Deyo R: Diagnostic evaluation of low back pain with emphasis on imaging. Ann Intern Med 137:586–597, 2002. Medline abstracts
  113. Ross MD, Boissonnault WG: Red flags: to screen or not to screen? J Orthop Sports Phys Ther 40(11):682–684, 2010. Medline abstracts
  114. Deftos LJ: Hypercalcemia in malignant and inflammatory diseases. Endocrinol Metab Clin North Am 31:141–158, 2002. Medline abstracts
  115. Nirenberg A: Managing hematologic toxicities. Cancer Nursing 26:32S–37S, 2003. Medline abstracts
  116. Barsevick A: Energy conservation and cancer-related fatigue. Rehabil Oncol 20:14–17, 2002.
  117. National Comprehensive Cancer Network (NCCN): Causes of cancer related fatigue, 2010. Available at www.nccn.org. Accessed on Oct. 11, 2010.
  118. Litterini AJ, Fieler VK: The change in fatigue, strength, and quality of life following a physical therapist prescribed exercise program for cancer survivors. Rehabil Oncol 26(3):11–17, 2008.
  119. Schmitz KH, Courneya KS: American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1409–1426, 2010. Medline abstracts
  120. Blaney J: The cancer rehabilitation journey: barriers to and facilitators of exercise among patients with cancer-related fatigue. Phys Ther 90(8):1135–1147, 2010. Medline abstracts
  121. Van Weert E: Cancer-related fatigue and rehabilitation. Phys Ther 90(10):1413–1425, 2010. Medline abstracts
  122. Volk K, Wruble E: Irradiation side effects and their impact on physical therapy. Acute Care Perspect 10:11–13, 2001.
  123. Winningham ML, McVicar M, Burke C: Exercise for cancer patients: guidelines and precautions. Phys Sportsmed 14:121–134, 1986.
  124. Goodman CC, Fuller K: Pathology: Implications for the physical therapist, ed 3, Philadelphia, 2009, WB Saunders.
  125. Jacobs AL: Adult cancer survivorship: evolution, research, and planning care. CA Cancer J Clin 59:391–410, 2009. Medline abstracts
  126. Miller KD, Triano LR: Medical issues in cancer survivors—a review. Cancer J 14(6):375–387, 2008. Medline abstracts
  127. Hile ES: Persistent mobility disability after neurotoxic chemotherapy. Phys Ther 90(11):1649–1657, 2010. Medline abstracts
  128. Asher A: Cancer rehabilitation and survivorship: Cedars-Sinai Medical Center experience. Oncol Nurse 3(6):1, 18–21, 2010.
  129. Shamley DR: Changes in shoulder muscle size and activity following treatment for breast cancer. Breast Cancer Res Treat 106(1):19–27, 2007. Medline abstracts
  130. Ahles TA: Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192–201, 2007. Medline abstracts
  131. Ferguson RJ: Management of chemotherapy-related cognitive dysfunction. In Feuerstein M, editor: Handbook of cancer survivorship, New York, 2006, Springer.
  132. Siegel HJ, Pressey JG: Current perspectives on the surgical and medical management of soft tissue sarcomas, Medscape 2008: Available at http://www.medscape.com/viewarticle/579883. Accessed Oct. 13, 2010.
  133. Borman H, Safak T, Ertoy D: Fibrosarcoma following radiotherapy for breast cancer: a case report and review of the literature. Ann Plast Surg 41:201–204, 1998. Medline abstracts
  134. National Cancer Institute (NCI): Treatment statement for health professionals: adult soft tissue sarcoma, Med News 2005. Available at www.meb.unibonn.de/cancer.gov/CDR0000062820.html. Accessed Oct. 13, 2010.
  135. Roll L: Cancer in children and adolescents. In Varricchio C, editor: ACS: A cancer source book for nurses, ed 8, Boston, 2004, Jones and Bartlett, pp 229–242.
  136. American Cancer Society (ACS): Cancer reference information. overview: osteosarcoma. Available at http://www.cancer.org/docroot/CRI/CRI_2_1x.asp?dt=52. Accessed Oct. 13, 2010.
  137. Maheshwari AV, Cheng EY: Ewing sarcoma family of tumors. J Am Acad Orthop Surg 18(2):94–107, 2010. Medline abstracts
  138. American Cancer Society (ACS): Cancer Reference information. Detailed guide: Ewing family of tumors. Available at http://www.cancer.org/Cancer/EwingFamilyofTumors/DetailedGuide/index. Accessed Oct. 12, 2010.
  139. Grubb MR, Currier BL, Pritchard DJ, et al: Primary Ewing sarcoma of the spine. Spine 19:309–313, 1994. Medline abstracts
  140. Lin PP: Secondary chondrosarcoma. J Am Acad Orthop Surg 18(10):608–615, 2010. Medline abstracts
  141. Resnick D: Diagnosis of bone and joint disorders, ed 4, Philadelphia, 2002, WB Saunders.
  142. Payne WT, Merrell G: Benign bone and soft tissue tumors of the hand. J Hand Surg 35A(11):1901–1910, 2010.
  143. Better outlook for people with brain tumors. Johns Hopkins Med Lett 14:3, 2002.
  144. Kasper D, longo D, Fauci A, et al: Harrison’s principles of internal medicine, ed 18, New York, 2011, McGraw-Hill.
  145. Volkow ND: Effects of cell phone radiofrequency signal exposure on brain glucose metabolism. JAMA 305(8):808–813, 2011. Medline abstracts
  146. Carney CP, Woolson RF, Jones L, et al: Occurrence of cancer among people with mental health claims in an insured population. Psychosom Med 66:735–743, 2004. Medline abstracts
  147. Hong WK: Holland-Frei cancer medicine, Shelton, CT, 2010, Peoples Medical Publishing House, 2010.
  148. Abu-Shakra M, Buskila D, Ehrenfeld M, et al: Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 60:433–441, 2001. Medline abstracts
  149. Zaidi A, Vesole H: Multiple myeloma: an old disease with new hope for the future. CA Cancer J Clin 51:273–285, 2001. Medline abstracts
  150. Paulson B, Gudas S: Multiple myeloma. Rehabil Oncol 21:8–10, 2003.
  151. Volker D: Other cancers: multiple myeloma. In Varricchio C, editor: ACS: Cancer source book for nurses, ed 8, Boston, 2004, Jones and Bartlett, pp 324–336.
  152. Jones A: Lymphomas. In Varricchio C, editor: ACS: A cancer source book for nurses, ed 8, Boston, 2004, Jones and Bartlett, pp 265–276.
  153. Lim ST, Levine AM: Recent advances in acquired immuno­deficiency syndrome (AIDS)-related lymphoma. CA Cancer J Clin 55:229–241, 2005. Medline abstracts
  154. Hardell L, Axelson O: Environmental and occupational aspects on the etiology of non-Hodgkin lymphoma. Oncol Res 10:1–5, 1998. Medline abstracts
  155. Gaidano G, Carbone A, Dalla-Favera R: Genetic basis of acquired immunodeficiency syndrome–related lymphomagenesis. J Natl Cancer Inst Monogr 23:95–100, 1998. Medline abstracts
  156. Aboulafia AJ, Khan F, Pankowsky D, et al: AIDS-associated secondary lymphoma of bone: a case report with review of the literature. Am J Orthop 27:128–134, 1998. Medline abstracts
  157. Gapstur SM, Morrow M, Sellers TA: Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women’s Health Study. JAMA 281:2091–2097, 1999. Medline abstracts
  158. Aubuchon M, Santoro N: Lessons learned from the WHI: HRT requires a cautious and individualized approach. Geriatrics 59:22–26, 2004. Medline abstracts
  159. Rossouw JE, Anderson GL, Prentice RL, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333, 2002. Medline abstracts
  160. Holden AF: Sweet’s syndrome in association with generalized granuloma annulare in a patient with previous breast carcinoma. Clin Exp Dermatol 26:668–670, 2001. Medline abstracts
  161. Bourke JF, Keohane S, Long CC, et al: Sweet’s syndrome and malignancy in the UK. Br J Dermatol 137:609–613, 1997. Medline abstracts
  162. Cohen PR, Kurzrock R: Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol 42:761–778, 2003. Medline abstracts